These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29619420)

  • 1. Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.
    Jeffery HC; Braitch MK; Bagnall C; Hodson J; Jeffery LE; Wawman RE; Wong LL; Birtwistle J; Bartlett H; Lohse AW; Hirschfield GM; Dyson J; Jones D; Hubscher SG; Klenerman P; Adams DH; Oo YH
    Hepatol Commun; 2018 Apr; 2(4):421-436. PubMed ID: 29619420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
    Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis.
    Ferri S; Longhi MS; De Molo C; Lalanne C; Muratori P; Granito A; Hussain MJ; Ma Y; Lenzi M; Mieli-Vergani G; Bianchi FB; Vergani D; Muratori L
    Hepatology; 2010 Sep; 52(3):999-1007. PubMed ID: 20683931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4
    Qu LM; Wang SH; Yang K; Brigstock DR; Sun L; Gao RP
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):133-139. PubMed ID: 29551296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis.
    Sakaki M; Hiroishi K; Baba T; Ito T; Hirayama Y; Saito K; Tonoike T; Kushima M; Imawari M
    Hepatol Res; 2008 Apr; 38(4):354-61. PubMed ID: 18021223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.
    Taubert R; Hardtke-Wolenski M; Noyan F; Wilms A; Baumann AK; Schlue J; Olek S; Falk CS; Manns MP; Jaeckel E
    J Hepatol; 2014 Nov; 61(5):1106-14. PubMed ID: 24882050
    [TBL] [Abstract][Full Text] [Related]  

  • 7.  Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis.
    Behairy BE; El-Araby HA; Abd El Kader HH; Ehsan NA; Salem ME; Zakaria HM; Khedr MA
    Ann Hepatol; 2016; 15(5):682-90. PubMed ID: 27493106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
    Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Imbalance between Foxp3
    Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
    J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.
    Vuerich M; Harshe R; Frank LA; Mukherjee S; Gromova B; Csizmadia E; Nasser IAM; Ma Y; Bonder A; Patwardhan V; Robson SC; Longhi MS
    J Hepatol; 2021 Jan; 74(1):48-57. PubMed ID: 32663496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease.
    Yuksel M; Nazmi F; Wardat D; Akgül S; Polat E; Akyildiz M; Arikan Ç
    Front Immunol; 2022; 13():1053216. PubMed ID: 36685568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
    Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis.
    Oo YH; Ackrill S; Cole R; Jenkins L; Anderson P; Jeffery HC; Jones N; Jeffery LE; Lutz P; Wawman RE; Athwal AK; Thompson J; Gray J; Guo K; Barton D; Hirschfield GM; Wong T; Guest P; Adams DH
    JHEP Rep; 2019 Oct; 1(4):286-296. PubMed ID: 32039380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis.
    Huang C; Shen Y; Shen M; Fan X; Men R; Ye T; Yang L
    Front Pharmacol; 2021; 12():726128. PubMed ID: 34531750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment.
    Renand A; Habes S; Mosnier JF; Aublé H; Judor JP; Vince N; Hulin P; Nedellec S; Métairie S; Archambeaud I; Brouard S; Gournay J; Conchon S
    Hepatol Commun; 2018 Aug; 2(8):968-981. PubMed ID: 30094407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sFgl2 gene-modified MSCs regulate the differentiation of CD4
    Ji W; Wang W; Li P; Liu Y; Zhang B; Qi F
    Stem Cell Res Ther; 2023 Nov; 14(1):316. PubMed ID: 37924141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic and peripheral blood phenotypes of natural killer and T cells: differential surface expression of killer cell immunoglobulin-like receptors.
    Podhorzer A; Machicote A; Belén S; Lauferman L; Imventarza O; Montal S; Marciano S; Galdame O; Podesta LG; Fainboim L
    Immunology; 2018 Jun; 154(2):261-273. PubMed ID: 29247515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
    Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
    J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.